Indonesia Hosts First Asia Pacific Regenerative Medicine Congress, Aims for Regional Leadership

Indonesia is pioneering the first Asia Pacific Regenerative Medicine Congress (APREMIC) 2026, held in Jakarta from July 2-4. This landmark event positions Indonesia as a leader in the region for regenerative medicine, with the ambition to become a global center for expertise in the field.

The congress, hosted at the Grand Hyatt hotel, convenes researchers and specialists from more than 20 countries. APREMIC 2026 Chairman, Dr. Cosmos Octavianus Mangunsong, articulated Indonesia's mission to contribute to global well-being by cultivating experts in scientific and medical fields, particularly regenerative medicine. "Together, we can achieve the target, heal the world with regenerative medicine. Let us collaborate to make this dream a reality," he stated, emphasizing the congress's role in fostering international cooperation.

APREMIC 2026 is a collaborative effort involving government, private sectors, and health institutions. Its primary goal is to demonstrate Indonesia's capacity to host international congresses in stem cell and regenerative medicine, thereby enhancing the nation's image on the global health stage. "The main goal is to introduce Indonesia to the world, showing that we are competitive, we have experts, and we are respected internationally as providers of stem cell and regenerative medicine services," Mangunsong added.

Dr. Jonny, President of the Indonesia Society Regenerative Medicine (INASRM), highlighted the transformative potential of regenerative medicine, focusing not just on longevity but on improving functional capacity, independence, and overall quality of life for patients. He stressed the importance of translating laboratory innovations into safe and effective patient treatments, which serves as the core spirit of APREMIC 2026. The congress encourages global researchers, academics, regulators, and industry leaders to collaborate in turning scientific advancements into real-world impacts.